San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has named Brandi L. Roberts as its Chief Financial Officer and Senior Vice President. Roberts has been VP, Finance at the company since March of 2011, and also has served at such firms as Alphatec Spine, Pfizer/Agouron, and PricewaterhouseCoopers LLP. ADVENTRX's lead compound is aimed at treating complications arising from sickle cell disease.
posted on Friday, January 4, 2013

Related stories:
> ADVENTRX Names Chief Medical Officer
> ADVENTRX Pharmaceuticals Raises $22.5M, Plans Acquisition
> ADVENTRX Becomes Mast Therapeutics
> Adventrx Reaches End Of Line, Looks For Buyer
> ADVENTRX Pharmaceuticals Gets $19.2M Home